A dry extract of organic humified material for cosmetic, medical or dietary use, wherein the dry extract comprises fulvic acid and humic acid, and is characterized by a maximum average particle size of 20 micrometer.

The invention comprises a defined and safe soil substitute, herein referred to as “deconstructed soil”, that supports ecological balance in anaerobic microbial ecosystems, such as that inside the human gut, by shifting energy availability to favor growth of bacteria linked with gut health, and away from the most dominant species and species that are putatively harmful. The invention enables vulnerable bacterial groups to recover from a state of apparent extinction from the ecosystem in question. As it does not contain components that are prebiotic or probiotic, the deconstructed soil represents a new product concept for preventing and treating conditions associated with dysfunctional microbial ecosystems in the gastrointestinal tract of humans and animals, as well as other anaerobic microbial ecosystems.

According to aspect of the present invention there is provided humus treatment process with active neurological substances, that is, the waste treatment process in the pharmaceutical industry. That uses raw materials from plants. The process involves treatment of fossil plants, Canabis sative, Mittragyna speciose, Datura metel and Magic mushrooms in order to allow residues in the plant to interact with the system. Nerves are depleted or less than the set value and allowing the production waste to be used in the processing of the fibers and agriculture industry.

The invention discloses an immunomodulatory composition comprising non-culturable bacteria, a method of production and an article and an apparatus for its use and administration.

The invention discloses an immunomodulatory composition comprising non-culturable bacteria, a method of production and an article and an apparatus for its use and administration.

This disclosure is directed to methods of treating, preventing, and protecting against viral infection including coronavirus infection and symptoms such as in COVID-19 infection. The methods include the administration of a composition comprising an extract and/or extract component, specifically, plant and/or herbo-mineral extracts, such as of Shilajit, Withania somnifera, Asparagus racemosus, Terminalia chebula, Terminaha bellirica, Phyllanthus emblica, Azadirachta indica, and a trivalent chromium complex with extracts of P. emblica and Shilajit; and/or extract components such as 3,8-dihydroxy-6H-benzo[c]chromen-6-one and 3-hydroxy-6H-benzo[c]chromen-6-one.

This disclosure is directed to methods of treating, preventing, and protecting against viral infection including coronavirus infection and symptoms such as in COVID-19 infection. The methods include the administration of a composition comprising an extract and/or extract component, specifically, plant and/or herbo-mineral extracts, such as of Shilajit, Withania somnifera, Asparagus racemosus, Terminalia chebula, Terminaha bellirica, Phyllanthus emblica, Azadirachta indica, and a trivalent chromium complex with extracts of P. emblica and Shilajit; and/or extract components such as 3,8-dihydroxy-6H-benzo[c]chromen-6-one and 3-hydroxy-6H-benzo[c]chromen-6-one.

Compositions with fulvate fractions alone or in combination with growth factors, bioactive fragmented peptides, or combinations thereof are disclosed herein. Also disclosed are methods of using said compositions for the catalyzing cellular regeneration, including the healing, treatment, or prevention of skin disorders. Also disclosed are methods for extracting, isolating, and purifying fulvate fractions for use in the manufacture of said compositions.

The present invention discloses a medicine for treatment or adjuvant treatment of acquired immunodeficiency syndrome, a preparation method thereof and use methods thereof. The medicine comprises: lightyellow sophora root, glabrous greenbrier rhizome, bark of Chinese corktree, raw sessile stemona root, alumen, coptis root, cortex dictamni, chinaberry bark and root-bark, pangolin scales, amber, eucommia bark, tree peony bark, clematis root, common cnidium fruit, Chinese angelica, licorice root, common macrocarpium fruit, barbary wolfberry fruit, medicinal indianmulberry root, cherokee rose fruit, chinaroot greenbier rhizome, akebia fruit, milkvetch root, Japanese climbing fern spore, asiatic pennywort herb, mulberry leaf and frankincense. The present invention not only provides the medicine capable of effectively treating the acquired immunodeficiency syndrome, but also enables the medicine to be capable of being used in conjunction with other medical technical means to easily achieve a more ideal treatment effect.

The present invention discloses a medicine for treatment or adjuvant treatment of acquired immunodeficiency syndrome, a preparation method thereof and use methods thereof. The medicine comprises: lightyellow sophora root, glabrous greenbrier rhizome, bark of Chinese corktree, raw sessile stemona root, alumen, coptis root, cortex dictamni, chinaberry bark and root-bark, pangolin scales, amber, eucommia bark, tree peony bark, clematis root, common cnidium fruit, Chinese angelica, licorice root, common macrocarpium fruit, barbary wolfberry fruit, medicinal indianmulberry root, cherokee rose fruit, chinaroot greenbier rhizome, akebia fruit, milkvetch root, Japanese climbing fern spore, asiatic pennywort herb, mulberry leaf and frankincense. The present invention not only provides the medicine capable of effectively treating the acquired immunodeficiency syndrome, but also enables the medicine to be capable of being used in conjunction with other medical technical means to easily achieve a more ideal treatment effect.